HRT Financial’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-195,707
| Closed | -$5.14M | – | 4258 |
|
|
2025
Q3 | $5.14M | Buy |
195,707
+104,777
| +115% | +$3.13M | 0.02% | 663 |
|
|
2025
Q2 | $2.41M | Buy |
90,930
+39,007
| +75% | +$1.03M | 0.01% | 837 |
|
|
2025
Q1 | $1.25M | Buy |
+51,923
| New | +$1.64M | 0.01% | 1028 |
|
|
2024
Q3 | – | Sell |
-396,583
| Closed | -$21M | – | 3259 |
|
|
2024
Q2 | $21M | Buy |
+396,583
| New | +$26M | 0.12% | 123 |
|
|
2024
Q1 | – | Sell |
-124,971
| Closed | -$2.33M | – | 3190 |
|
|
2023
Q4 | $2.33M | Buy |
+124,971
| New | +$1.63M | 0.02% | 581 |
|
|
2023
Q2 | – | Sell |
-271,255
| Closed | -$4.52M | – | 3391 |
|
|
2023
Q1 | $4.52M | Sell |
271,255
-108,311
| -29% | -$1.12M | 0.06% | 275 |
|
|
2022
Q4 | $3.57M | Buy |
+379,566
| New | +$1.69M | 0.05% | 365 |
|
|
2022
Q3 | – | Sell |
-176,166
| Closed | -$509K | – | 3613 |
|
|
2022
Q2 | $509K | Sell |
176,166
-57,900
| -25% | -$143K | 0.01% | 1462 |
|
|
2022
Q1 | $702K | Buy |
234,066
+123,108
| +111% | +$442K | 0.01% | 1383 |
|
|
2021
Q4 | $510K | Buy |
110,958
+40,203
| +57% | +$225K | ﹤0.01% | 1741 |
|
|
2021
Q3 | $444K | Buy |
70,755
+50,271
| +245% | +$311K | ﹤0.01% | 2101 |
|
|
2021
Q2 | $122K | Buy |
+20,484
| New | +$122K | ﹤0.01% | 2544 |
|
|
2021
Q1 | – | Sell |
-16,801
| Closed | -$94K | – | 3223 |
|
|
2020
Q4 | $94K | Buy |
+16,801
| New | +$102K | ﹤0.01% | 1643 |
|
|
2019
Q1 | – | Sell |
-45,631
| Closed | -$349K | – | 813 |
|
|
2018
Q4 | $349K | Buy |
+45,631
| New | +$546K | 0.05% | 306 |
|
Other funds holding VKTX
VCM
VPM
